Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 6, 2004, Pages 699-706

  Suzuki, Yoshiyuki ^a   Arase, Yasuji ^a   Ikeda, Kenji ^a   Saitoh, Satoshi ^a   Tsubota, Akihito ^a   Suzuki, Fumitaka ^a   Kobayashi, Masahiro ^a   Akuta, Norio ^a   Someya, Takashi ^a   Miyakawa, Yuzo ^b   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

^b Miyakawa Memorial Research Foundation   (Japan)

Author keywords

Acidophilic body; Autoimmune hepatitis; Overlap syndrome; Primary biliary cirrhosis

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GEOGRAPHY; HUMAN; JAPAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 3042783419     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2004.03372.x     Document Type: Article

References (34)

1. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998-1005.
2. Alvarez F, Berg PA, Bianchi FB et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J. Hepatol. 1999; 31: 929-38.
3. Toda G, Zeniya M, Watanabe F et al. Present status of autoimmune hepatitis in Japan - correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J. Hepatol. 1997; 26: 1207-12.
4. Munoz LE, Thomas HC, Scheuer PJ, Doniach D, Sherlock S. Is mitochondrial antibody diagnostic of primary biliary cirrhosis? Gut 1981; 22: 136-40.
5. Gershwin ME, Coppel RL, Mackay IR. Primary biliary cirrhosis and mitochondrial autoantigens - insights from molecular biology. Hepatology 1988; 8: 147-51.
6. Van de Water J, Cooper A, Surh CD et al. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N. Engl. J. Med. 1989; 320: 1377-80.
7. Goodman ZD, McNally PR, Davis DR, Ishak KG. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig. Dis. Sc. 1995; 40: 1232-42.
8. Michieletti P, Wanless IR, Katz A et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 1994; 35: 260-5.
9. Kim WR, Poterucha JJ, Jorgensen RA et al. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. Hepatology 1997; 26: 22-6.
10. Kinoshita H, Omagari K, Whittingham S et al. Autoimmune cholangitis and primary biliary cirrhosis - an autoimmune enigma. Liver 1999; 19: 122-8.
11. Klatskin G, Kantor FS. Mitochondrial antibody in primary biliary cirrhosis and other diseases. Ann. Intern. Med. 1972; 77: 533-41.
12. Geubel AP, Baggenstoss AH, Summerskill WH. Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome. Gastroenterology 1976; 71: 444-9.
13. Kenny RP, Czaja AJ, Ludwig J, Dickson ER. Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis. Dig. Dis. Sci. 1986; 31: 705-11.
14. Shouval D, Eliakim M, Levij IS. Chronic active hepatitis with cholestatic features. II. A histopathological study. Am. J. Gastroenterol. 1979; 72: 551-5.
15. Kaplan MM. Primary biliary cirrhosis. N. Engl. J. Med. 1996; 335: 1570-80.
16. Krawitt EL. Autoimmune hepatitis. N. Engl. J. Med. 1996; 334: 897-903.
17. Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 1998; 28: 360-5.
18. Davis PA, Leung P, Manns M et al. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena? Hepatology 1992; 16: 1128-36.
19. Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis - autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998; 28: 296-301.
20. Mackay IR, Gershwin ME. Primary biliary cirrhosis: current knowledge, perspectives, and future directions. Semin. Liver Dis. 1989; 9: 149-57.
21. Kloppel G, Seifert G, Lindner H, Dammermann R, Sack HJ, Berg PA. Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity. Virchows Arch. A. Pathol. Anat. Histol. 1977; 373: 143-60.
22. Duclos-Vallee JC, Hadengue A, Ganne-Carrie N, Robin E, Degott C, Erlinger S. Primary biliary cirrhosis - autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A. Dig. Dis. Sci. 1995; 40: 1069-73.
23. Perrillo RP, Mason AL, Jacob S, Gerber MA. Hepatitis and cholestasis in a middle-aged woman. Hepatology 1996; 24: 730-4.
24. Czaja AJ. The variant forms of autoimmune hepatitis. Ann. Intern. Med. 1996; 125: 588-98.
25. Brunner G, Klinge O. A cholangitis with antinuclear antibodies (immunocholangitis) resembling chronic non-supprative destructive cholangitis. Dtsch. Med. Wochenschr. 1987; 112: 1454-8.
26. Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 1993; 18: 10-15.
27. Doniach D, Walker JG. A unified concept of autoimmune hepatitis. Lancet 1969; 1: 813-15.
28. Boberg KM, Fausa O, Haaland T et al. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 1996; 23: 1369-76.
29. Invernizzi P, Crosignani A, Battezzati PM et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and - negative primary biliary cirrhosis. Hepatology 1997; 25: 1090-5.
30. Mitchison HC, Palmer JM, Bassendine MF, Watson AJ, Record CO, James OF. A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. J. Hepatol. 1992; 15: 336-44.
31. Lohse AW, zum Buschenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis, evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 1999; 29: 1078-84.
32. Nishioka M, Morshed SA, McFarlane IG et al. Geographical variation in the frequency and characteristics of autoimmune liver diseases. In: Krawitt EL, Wiesner RH, Nishioka M, eds. Autoimmune Liver Diseases, 2nd edn. Amsterdam: Elsevier Science, 1998; 413-24.
33. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand. J. Gastroenterol. 1998; 33: 99-103.
34. Triger DR, Berg PA, Rodes J. Epidemiology of primary biliary cirrhosis. Liver 1984; 4: 195-200.